| Higher SES |  | Lower SES |  |
---|---|---|---|---|
 | Mean (SD) | N | Mean (SD) | N |
Baseline | Â | Â | Â | Â |
Age (years) | 53.3 (5.6) | 8824 | 55.2 (5.7) | 3315 |
Male | 44.9% | 8824 | 40.7% | 3315 |
Framingham risk score | 5.8 (6.0) | 8824 | 7.0 (6.6) | 3315 |
Total cholesterol (mg/dL) | 212.3 (40.1) | 8824 | 216.4 (43.7) | 3315 |
HDL cholesterol mg/dL) | 52.7 (17.0) | 8824 | 52.9 (17.2) | 3315 |
Systolic blood pressure (mm Hg) | 118.0 (16.9) | 8824 | 125.2 (20.0) | 3315 |
Current smoker | 22.9% | 8824 | 34.9% | 3315 |
Anti-hypertensive medication | 17.8% | 8785 | 28.8% | 3300 |
3-year follow-up | Â | Â | Â | Â |
Total cholesterol (mg/dL) | 207.8 (37.8) | 8451 | 211.0 (40.3) | 2928 |
HDL cholesterol (mg/dL) | 50.5 (16.8) | 8424 | 50.3 (16.8) | 2922 |
Systolic blood pressure (mm Hg) | 119.2 (17.5) | 8483 | 125.1 (20.2) | 2945 |
Current smoker | 19.8% | 8467 | 29.6% | 2932 |
Anti-hypertensive medication | 20.4% | 8457 | 31.9% | 2928 |
6-year follow-up | Â | Â | Â | Â |
Total cholesterol (mg/dL) | 206.6 (36.4) | 7844 | 208.8 (39.4) | 2500 |
HDL cholesterol (mg/dL) | 53.1 (18.3) | 7843 | 52.1 (17.8) | 2500 |
Systolic blood pressure (mm Hg) | 122.2 (17.8) | 7869 | 128.7 (20.5) | 2515 |
Current smoker | 15.9% | 7848 | 23.5% | 2494 |
Anti-hypertensive medication | 25.6% | 7834 | 37.4% | 2498 |
9-year follow-up | Â | Â | Â | Â |
Total cholesterol (mg/dL) | 200.7 (35.9) | 6974 | 202.1 (38.8) | 1990 |
HDL cholesterol (mg/dL) | 50.6 (16.6) | 6974 | 49.4 (16.1) | 1990 |
Systolic blood pressure (mm Hg) | 125.3 (18.1) | 6994 | 130.6 (19.5) | 2001 |
Current smoker | 13.0% | 6969 | 19.5% | 1991 |
Anti-hy2ertensive medication | 30.5% | 6965 | 42.3% | 1988 |